| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.833 | 0.004 | 0.833 | Hypolipemic | 0.81 0.004 CID_3364535 0.809 0.004 CID_3364534 | ||
| 0.547 | 0.005 | 0.55 | NOS3 expression enhancer | 0.55 0.005 CID_3364535 0.51 0.005 CID_3364534 | CID_3364535 | |
| 0.418 | 0.004 | 0.438 | Cholesterol synthesis inhibitor | 0.438 0.003 CID_3364535 0.404 0.004 CID_3364534 | CID_3364535 | |
| 0.342 | 0.001 | 0.342 | HMG CoA reductase inhibitor | 0.252 0.001 CID_3364535 0.252 0.001 CID_3364534 | ||
| 0.302 | 0.015 | 0.311 | Insulin sensitizer | 0.311 0.014 CID_3364535 0.28 0.021 CID_3364534 | CID_3364535 | |
| 0.288 | 0.054 | 0.288 | Interleukin agonist | 0.267 0.067 CID_3364535 0.228 0.096 CID_3364534 | ||
| 0.279 | 0.06 | 0.279 | Platelet antagonist | 0.252 0.071 CID_3364535 0.246 0.074 CID_3364534 | ||
| 0.274 | 0.094 | 0.28 | Interleukin 2 agonist | 0.28 0.089 CID_3364535 0.258 0.11 CID_3364534 | CID_3364535 | |
| 0.322 | 0.144 | 0.322 | Cyclophilin D inhibitor | 0.319 0.146 CID_3364535 0.317 0.147 CID_3364534 | ||
| 0.266 | 0.112 | 0.301 | Sodium/bile acid cotransporter inhibitor | 0.3 0.079 CID_3364535 0.301 0.078 CID_3364534 | CID_3364534 | |
| 0.15 | 0.01 | 0.15 | Prostaglandin EP2 antagonist | 0.136 0.011 CID_3364535 0.129 0.013 CID_3364534 | ||
| 0.126 | 0.011 | 0.126 | Sphingosine 1-phosphate receptor antagonist | 0.12 0.013 CID_3364535 0.09 0.03 CID_3364534 | ||
| 0.254 | 0.144 | 0.254 | Immunosuppressant | 0.253 0.145 CID_3364535 0.235 0.161 CID_3364534 | ||
| 0.111 | 0.008 | 0.111 | Prostaglandin F2 alpha antagonist | 0.106 0.009 CID_3364535 0.102 0.01 CID_3364534 | ||
| 0.108 | 0.006 | 0.108 | Sphingosine 1-phosphate receptor 3 antagonist | 0.104 0.007 CID_3364535 0.088 0.013 CID_3364534 | ||
| 0.198 | 0.111 | 0.201 | Tumour necrosis factor alpha release inhibitor | 0.201 0.108 CID_3364535 0.193 0.115 CID_3364534 | CID_3364535 | |
| 0.163 | 0.077 | 0.176 | Growth hormone agonist | 0.176 0.07 CID_3364535 0.153 0.085 CID_3364534 | CID_3364535 | |
| 0.085 | 0.021 | 0.085 | Prostaglandin antagonist | 0.062 0.031 CID_3364535 0.057 0.034 CID_3364534 | ||
| 0.082 | 0.02 | 0.082 | Nitric oxide donor | 0.078 0.024 CID_3364535 0.076 0.026 CID_3364534 | ||
| 0.168 | 0.108 | 0.168 | Platelet aggregation inhibitor | 0.143 0.137 CID_3364535 | ||
| 0.102 | 0.045 | 0.11 | Bile acid receptor antagonist | 0.11 0.031 CID_3364535 0.091 0.072 CID_3364534 | CID_3364535 | |
| 0.158 | 0.106 | 0.16 | P-glycoprotein inhibitor | 0.16 0.101 CID_3364535 0.152 0.114 CID_3364534 | CID_3364535 | |
| 0.094 | 0.05 | 0.094 | ATPase (Vacuolar H+) inhibitor | 0.094 0.049 CID_3364535 0.092 0.053 CID_3364534 | ||
| 0.063 | 0.023 | 0.064 | Leukotriene C antagonist | 0.064 0.021 CID_3364535 0.062 0.024 CID_3364534 | CID_3364535 | |
| 0.147 | 0.109 | 0.155 | Platelet adhesion inhibitor | 0.155 0.101 CID_3364535 | CID_3364535 | |
| 0.062 | 0.026 | 0.062 | Sphingosine 1-phosphate receptor 1 antagonist | 0.058 0.032 CID_3364535 | ||
| 0.102 | 0.066 | 0.113 | Toll-Like receptor 4 antagonist | 0.113 0.051 CID_3364535 0.1 0.069 CID_3364534 | CID_3364535 | |
| 0.126 | 0.091 | 0.142 | Farnesoid X receptor antagonist | 0.142 0.062 CID_3364535 0.134 0.075 CID_3364534 | CID_3364535 | |
| 0.129 | 0.097 | 0.129 | MAP3K9 inhibitor | 0.127 0.1 CID_3364535 | ||
| 0.127 | 0.1 | 0.127 | Insulin secretagoues | 0.127 0.1 CID_3364535 | ||
| 0.142 | 0.117 | 0.142 | Lipocortins synthesis antagonist | 0.135 0.13 CID_3364535 0.135 0.13 CID_3364534 | ||
| 0.142 | 0.116 | 0.144 | ATPase inhibitor | 0.144 0.112 CID_3364535 | CID_3364535 | |
| 0.197 | 0.172 | 0.27 | Transcription factor NF kappa B inhibitor | 0.27 0.113 CID_3364535 0.22 0.151 CID_3364534 | CID_3364535 | |
| 0.06 | 0.04 | 0.06 | Cathepsin E inhibitor | 0.057 0.045 CID_3364535 0.056 0.047 CID_3364534 | ||
| 0.126 | 0.107 | 0.139 | Phospholipase A2 inhibitor | 0.135 0.092 CID_3364535 0.139 0.087 CID_3364534 | CID_3364534 | |
| 0.041 | 0.022 | 0.041 | Leukotriene C4 antagonist | 0.041 0.021 CID_3364535 0.04 0.024 CID_3364534 | ||
| 0.19 | 0.172 | 0.19 | Nootropic | |||
| 0.112 | 0.094 | 0.127 | Bone formation stimulant | 0.127 0.079 CID_3364535 | CID_3364535 | |
| 0.029 | 0.016 | 0.029 | Prostaglandin EP4 antagonist | |||
| 0.038 | 0.032 | 0.038 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.09 | 0.087 | 0.09 | Folate antagonist | |||
| 0.088 | 0.099 | 0.093 | Interleukin 1b antagonist | 0.093 0.091 CID_3364534 | CID_3364534 | |
| 0.024 | 0.039 | 0.031 | ATP citrate lysase inhibitor | 0.029 0.027 CID_3364535 0.031 0.024 CID_3364534 | CID_3364534 | |
| 0.129 | 0.165 | 0.145 | Catenin beta inhibitor | 0.145 0.119 CID_3364535 | CID_3364535 | |
| 0.088 | 0.127 | 0.118 | Toll-Like receptor 2 antagonist | 0.118 0.08 CID_3364535 | CID_3364535 | |
| 0.102 | 0.143 | 0.116 | Papain-like protease (SARS coronavirus) inhibitor | 0.116 0.092 CID_3364535 | CID_3364535 | |
| 0.038 | 0.089 | 0.053 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.053 0.048 CID_3364535 | CID_3364535 | |
| 0.032 | 0.103 | 0.056 | CXC chemokine 1 receptor antagonist | 0.056 0.028 CID_3364534 | CID_3364534 | |
| 0.106 | 0.178 | 0.168 | Interleukin antagonist | 0.135 0.13 CID_3364535 0.168 0.105 CID_3364534 | CID_3364534 | |
| 0.169 | 0.248 | 0.233 | Histamine release inhibitor | 0.233 0.169 CID_3364534 | CID_3364534 | |
| 0.186 | 0.296 | 0.237 | Apoptosis agonist | 0.237 0.229 CID_3364535 | CID_3364535 | |
| 0.065 | 0.221 | 0.123 | Interleukin 4 antagonist | 0.123 0.081 CID_3364534 | CID_3364534 | |
| 0.032 | 0.244 | 0.062 | Potassium channel large-conductance Ca-activated activator | 0.062 0.056 CID_3364534 | CID_3364534 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |